Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Role of PML and the PML-nuclear body in the control of programmed cell death

Oncogene volume 22, pages 9048–9057 (2003)Cite this article

Abstract

PML is a tumor suppressor implicated in leukemia and cancer pathogenesis. PML epitomizes a multiprotein nuclear structure, the PML-nuclear body (PML-NB), whose proper formation and function depends on PML. Studies in knockout (KO) mice and cells unraveled an essential pleiotropic role for PML in multiple p53-dependent and -independent apoptotic pathways. As a result, Pml−/− mice and cells are protected from apoptosis triggered by a number of stimuli such as ionizing radiation, interferon, ceramide, Fas and TNF. It is becoming apparent that PML and the PML-NB act as molecular hubs for the induction and/or reinforcement of programmed cell death through a selective and dynamic regulation of proapoptotic transcriptional events. In addition, recent observations propose a role for PML in checkpoint responses upon DNA damage. Moreover, PML and the PML-NB have also been implicated in the control of genomic stability and DNA repair. Here, we will discuss the molecular mechanisms by which PML regulates these processes and the implication of these findings for cancer pathogenesis and therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE and Haber DA . (1999). Science, 286, 2528–2531.

  • Best JL, Ganiatsas S, Agarwal S, Changoo A, Salomoni P, Shirihai O, Meluh PB, Pandolfi PP, and Zon LI . (2002). Mol. Cell, 10, 843–855.

  • Bischof O, Kim SH, Irving J, Beresten S, Ellis NA and Campisi J . (2001). J. Cell. Biol., 153, 367–380.

  • Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H and Chung JH . (1999). Proc. Natl. Acad. Sci. USA, 96, 3745–3750.

  • Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR . (1995). EMBO J., 14, 4240–4248.

  • Carbone R, Pearson M, Minucci S and Pelicci PG . (2002). Oncogene, 21, 1633–1640.

  • Chang KS, Fan YH, Andreeff M, Liu J and Mu ZM . (1995). Blood, 85, 3646–3653.

  • Changou AC, Hilgenfeld E, McNell N, He L-Z, Montagna C, Ried T and Pandolfi PP . (2001). Blood, 98, 98a.

  • Chehab NH, Malikzay A, Appel M and Halazonetis TD . (2000). Genes Dev., 14, 278–288.

  • D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, Piaggio G, Fanciulli M, Appella E and Soddu S . (2002). Nat. Cell Biol., 4, 11–19.

  • Dunham MA, Neumann AA, Fasching CL and Reddel RR . (2000). Nat. Genet., 26, 447–450.

  • Ecsedy JA, Michaelson JS and Leder P . (2003). Mol. Cell. Biol., 23, 950–960.

  • Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M and German J . (1995). Cell, 83, 655–666.

  • Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C and Lowe SW . (2000). Genes Dev., 14, 2015–2027.

  • Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C and Del Sal G . (2000). EMBO J., 6, 185–195.

  • Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W and Pandolfi PP . (2000). Nat. Cell Biol., 2, 730–736.

  • Grande MA, van der Kraan I, van Steensel B, Schul W, de The H, van der Voort HT, de Long L and Driel R . (1996). J. Cell. Biochem., 63, 280–291.

  • Grobelny JV, Kulp-McEliece M and Broccoli D . (2001). Hum. Mol. Genet., 10, 1953–1961.

  • Haber RS . (1998). Cell, 95, 583–586.

  • Hanada K, Ukita T, Kohno Y, Saito K, Kato J and Ikeda H . (1997). Proc. Natl. Acad. Sci. USA, 94, 3860–3865.

  • Harmon FG and Kowalczykowski SC . (1998). Genes Dev., 12, 1134–1144.

  • He LZ, Tribioli C, Rivi R, Peruzzi D, Soares V, Pelicci PG, Cattoretti G and Pandolfi PP . (1997). Proc. Natl. Acad. Sci. USA, 94, 5302–5307.

  • Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ and Mak TW . (2000). Science, 287, 1824–1827.

  • Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W, Will H and Schmitz ML . (2002). Nat. Cell Biol., 4, 1–10.

  • Jensen K, Shiels C and Freemont PS . (2001). Oncogene, 20, 7223–7233.

  • Karanjawala ZE, Grawunder U, Hsieh CL and Lieber MR . (1999). Curr. Biol., 9, 1501–1504.

  • Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P and de Thé H . (2001). J. Exp. Med., 193, 1361–1371.

  • Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, Grosveld F, Pandolfi PP, Pelicci PG and Dejean A . (1995). Oncogene, 11, 871–876.

  • Le S, Moore GK, Haber JE and Greider CW . (1999). Genetics, 152, 143–152.

  • Le Beau MM, Davis EM, Patel B, Phan VT, Sohal J and Kogan SC . (2003). Blood. April 10, Epub. Ahead of print.

  • Lendvay TS, Morris DK, Sah J, Balasubramanian B and Lundblad V . (1996). Genetics, 144, 1399–1412.

  • Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ and Chen JD . (2000). Mol. Cell. Biol., 20, 1784–1796.

  • Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J and Gu W . (2002). Nature, 416, 648–653.

  • Lombard DB and Guarente L . (2000). Cancer Res., 60, 2331–2334.

  • Lundblad V and Blackburn EH . (1993). Cell, 73, 347–360.

  • Maser RS, Monsen KJ, Nelms BE and Petrini JH . (1997). Mol. Cell. Biol., 17, 6087–6096.

  • Matsuoka S, Huang M and Elledge SJ . (1998). Science, 282, 1893–1897.

  • Melnick A and Licht JD . (1999). Blood, 93, 3167–3215.

  • Michaelson JS, Bader D, Kuo F, Kozak C and Leder P . (1999). Genes Dev., 13, 1918–1923.

  • Mirzoeva OK and Petrini JH . (2001). Mol. Cell. Biol., 21, 281–288.

  • Mirzoeva OK and Petrini JH . (2003). Mol. Cancer Res., 1, 207–218.

  • Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, LoCoco F, Rambaldi A, Grignani F et al. (1992). EMBO J., 11, 1397–1407.

  • Pandolfi PP . (2001). Oncogene, 20, 5726–5735.

  • Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP and Pelicci PG . (2000). Nature, 406, 207–210.

  • Perlman R, Schiemann WP, Brooks MW, Lodish HF and Weinberg RA . (2001). Nat. Cell Biol., 3, 708–714.

  • Piazza F, Gurrieri C and Pandolfi PP . (2001). Oncogene, 20, 7216–7222.

  • Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC and de Thé H . (1998). Nat. Genet., 20, 259–265.

  • Rego E, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C and Pandolfi PP . (2001). J. Exp. Med., 23, 521–529.

  • Salomoni P and Pandolfi PP . (2000). Nat. Med., 6, 742–744.

  • Shimoda K, Kamesaki K, Numata A, Aoki K, Matsuda T, Oritani K, Tamiya S, Kato K, Takase K, Imamura R, Yamamoto T, Miyamoto T, Nagafuji K, Gondo H, Nagafuchi S, Nakayama K and Harada M . (2002). J. Immunol., 169, 4707–4711.

  • Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saïb A, Quignon F, Pelicano L, Guillemin MC, Schindler C and de Thé H . (1995). Oncogene, 11, 2565–2573.

  • Terris B, Baldin V, Dubois S, Degott C, Flejou JF, Henin D and Dejean A . (1995). Cancer Res., 55, 1590–1597.

  • Torii S, Egan DA, Evans RA and Reed JC . (1999). EMBO J., 18, 6037–6049.

  • Wang XW, Tseng A, Ellis NA, Spillare EA, Linke SP, Robles AI, Seker H, Yang Q, Hu P, Beresten S, Bemmels NA, Garfield S and Harris CC . (2001). J. Biol. Chem., 276, 32948–32955.

  • Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F and Pandolfi PP . (1998a). Science, 279, 1547–1551.

  • Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R and Pandolfi PP . (1998b). Nat. Genet., 20, 266–271.

  • Wiesmeijer K, Molenaar C, Bekeer IM, Tanke HJ and Dirks RW . (2002). J. Struct. Biol., 140, 180–188.

  • Wu G, Lee WH and Chen PL . (2000). J. Biol. Chem., 275, 30618–30622.

  • Wu WS, Xu ZX and Chang KS . (2002). J. Biol. Chem., 277, 31734–31739.

  • Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP and Chang KS . (2003). J. Biol. Chem., 278, 12294–12304.

  • Wu X, Webster SR and Chen J . (2001). J. Biol. Chem., 276, 2971–2974.

  • Yang S, Kuo C, Bisi JE and Kim MK . (2002). Nat. Cell Biol., 4, 865–870.

  • Yankiwski V, Marciniak RA, Guarente L and Neff NF . (2000). Proc. Natl. Acad. Sci. USA, 97, 5214–5219.

  • Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR and Reddel RR . (1999). Cancer Res., 59, 4175–4179.

  • Zhong S, Hu P, Ye TZ, Stan R, Ellis NA and Pandolfi PP . (1999). Oncogene, 18, 7941–7947.

  • Zhong S, Muller S, Freemont PS, Dejean A and Pandolfi PP . (2000a). Blood, 95, 2748–2753.

  • Zhong S, Salomoni P and Pandolfi PP . (2000b). Nat. Cell Biol., 2, E85–E90.

  • Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D and Pandolfi PP . (2000c). J Exp. Med., 191, 631–640.

  • Zimonjic DB, Pollok JL, Westervelt P, Popescu NC and Ley TJ . (2000). Proc. Natl. Acad. Sci. USA, 97, 13306–13311.

Download references

Acknowledgements

We would like to thank members of the laboratory of Molecular and Developmental Biology (MADB) lab at the Memorial Sloan-Kettering Cancer Center for useful discussions. R.B. was a recipient of a T32 training grant from the NIH. This work was supported by the NCI, the De Witt Wallace Fund for Memorial Sloan-Kettering Cancer Center, the MMHCC and NIH Grants to P.P.P.

Author information

Authors and Affiliations

  1. Molecular Biology Program and Department of Pathology, Sloan-Kettering Division, Memorial Sloan-Kettering Cancer Center, Graduate School of Medical Sciences, Cornell University, 1275 York Avenue, New York, 10021, NY, USA

    Rosa Bernardi & Pier Paolo Pandolfi

Authors
  1. Rosa Bernardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pier Paolo Pandolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pier Paolo Pandolfi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernardi, R., Pandolfi, P. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22, 9048–9057 (2003). https://doi.org/10.1038/sj.onc.1207106

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207106

Keywords

This article is cited by

Search

Advanced search

Quick links